Latest Dividend News

Eagers Automotive reported a record-breaking 2024 with $11.2 billion in revenue and maintained its dividend, while securing a pivotal retail agreement with BYD Australia and unveiling a new community initiative.

Yancoal Australia Ltd reported robust 2024 financial results and outlined key corporate governance actions at its 2025 Annual General Meeting, reinforcing its position as a leading coal producer amid market challenges.

Web Travel Group reported a 22% rise in Total Transaction Value to $4.9 billion for FY25, while underlying EBITDA dipped 13% amid margin pressures and strategic investments. The company completed a $150 million share buyback to mitigate dilution risks and is optimistic about a strong FY26 start.

Web Travel Group Limited has reported a robust 22% increase in total transaction value following its strategic demerger, yet earnings were weighed down by margin compression and operational costs. The company is recalibrating its strategy to stabilize margins and pursue ambitious growth targets.

Fisher & Paykel Healthcare has reported a record full-year revenue of NZ$2.02 billion for FY2025, alongside a 43% increase in underlying net profit after tax. The company also raised its dividend, reflecting strong operational performance and strategic investments.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

Smartpay Holdings Limited reported a 9% increase in revenue to NZD 104.7 million for FY2025 but recorded a net loss and suspended its dividend, signaling challenges ahead despite top-line growth.

ALS Limited has announced an ordinary dividend of AUD 0.197 per share for the half-year ending March 2025, payable in July with flexible currency options for shareholders worldwide.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

Straker Limited’s FY2025 results reveal a modest revenue decline alongside a dramatic reduction in net losses, signaling a potential turning point for the translation services provider.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.